Veravas
PrivateLast Round
Accelerator
Jun 5, 2025
Total Funding Raised
$4M
Company Overview
Veravas operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was an Accelerator round in June 2025.
Veravas is a biotechnology company that provides a platform to manage sample preparation and diagnostic solutions for early disease detection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Veravas Comparables
Compare Veravas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diadem | 81% | |
| ALZpath, Inc. | 77% | |
| NeuroDex | 76% |
For institutional investors. Book with your work email.
Veravas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 5, 2025 | ||||
| Convertible Debt | Feb 19, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Veravas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| American Heart Association Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 287% MoM.
- Jan 21, 2026
Monthly visitors increased 53% MoM.
For institutional investors. Book with your work email.
Veravas Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Veravas's valuation, stock price, and market status.
Is Veravas a public or private company?
Veravas is a private company.
What is the current stock price of Veravas?
Veravas is a private company, so its shares have no public market price. Caplight tracks Veravas's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Veravas worth (valuation)?
Valuation information for Veravas is not publicly available.
Can I buy Veravas stock?
Veravas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Veravas's last funding round?
Veravas's most recent funding round was Accelerator on June 5, 2025.
Who are the main investors in Veravas?
Key investors in Veravas include MedTech Innovator, American Heart Association Ventures.
Will Veravas IPO soon?
No public IPO plans have been announced for Veravas.
How can I track Veravas secondary market activity?
Caplight tracks bids, offers, and trades in Veravas's shares on secondary markets.